Tag - ONCO

Executive Moves

Onco appoints Dr. Michael Lock to scientific and clinical advisory board

Onco-Innovations (CBOE CA: ONCO; Frankfurt: W1H, WKN: A3EKSZ; OTCQB: ONNVF) has announced the appointment of staff radiation oncologist, Dr. Michael Lock, to its scientific and clinical advisory board. Dr. Lock is a...

September 23, 2025

Developments

Onco-Innovations’ technology aims to transform cancer treatments

Onco-Innovations (CSE:ONCO; FRANKFURT:W1H; WKN:A3EKSZ) has announced that its exclusively-licensed, patented polynucleotide kinase 3’-phosphates (PNKP) inhibitors technology holds the potential to significantly enhance...

January 9, 2025

Tag - ONCO

Onco appoints Dr. Michael Lock to scientific and clinical advisory board

Onco-Innovations’ technology aims to transform cancer treatments

Subscribe